Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Industry Satellite Symposium 3
- Type: Industry Satellite Symposium
- Presentations: 4
- Coordinates: 5/06/2017, 13:00 - 14:00, Room A
-
+
Choices across treatment lines: Maximising patient outcomes in advanced or metastatic NSCLC
13:00 - 13:05 | Author(s): L. Paz-Ares
- Abstract
No abstract available for this presentation
-
+
Individualising treatment options to improve squamous NSCLC patient outcomes
13:05 - 13:30 | Author(s): E. Smit
- Abstract
No abstract available for this presentation
-
+
Patient pathways in rapid progression
13:30 - 13:55 | Author(s): B. Besse
- Abstract
No abstract available for this presentation
-
+
Closing remarks
13:55 - 14:00 | Author(s): L. Paz-Ares
- Abstract
No abstract available for this presentation
-
+
Keynote lecture: Genetic profiling of lung cancer
- Type: Keynote Lecture
- Presentations: 1
- Moderators:M. Reck
- Coordinates: 5/06/2017, 14:10 - 14:40, Room B
-
+
Genetic profiling of lung cancer
14:10 - 14:40 | Author(s): M. Meyerson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Imaging and locally advanced NSCLC
- Type: Poster Discussion session
- Presentations: 12
- Moderators:H. Prosch
- Coordinates: 5/06/2017, 14:45 - 15:45, Room W
-
+
45PD - Mediastinal nodal staging of non-small cell lung cancer using PET-CT in a tuberculosis-endemic country
14:45 - 14:45 | Author(s): B.B. Khurse
- Abstract
Loading... -
+
46PD - The solid component evaluated on computed tomography can predict the invasiveness and lymph node metastasis in lung adenocarcinoma as well as pathological invasive size
14:45 - 14:45 | Author(s): Y. Sakao
- Abstract
Loading... -
+
Invited Discussant 45PD and 46PD
14:45 - 15:00 | Author(s): H. Prosch
- Abstract
No abstract available for this presentation
-
+
Discussion
15:00 - 15:05
- Abstract
No abstract available for this presentation
-
+
61PD - Recurrence risk-scoring model for resected stage I lung adenocarcinoma with solid component
15:05 - 15:05 | Author(s): J. Qian
- Abstract
Loading... -
+
72PD - Video-Assisted Thoracic Surgery (VATS) lobectomy for non-small cell lung cancer after induction chemotherapy: A propensity score-matched analysis on behalf of the Italian VATS group
15:05 - 15:05 | Author(s): L. Bertolaccini
- Abstract
Loading... -
+
Invited Discussant 61PD and 72PD
15:05 - 15:20 | Author(s): P. Van Schil
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
15:20 - 15:25
- Abstract
No abstract available for this presentation
-
+
73PD - Prognostic value of pre- to post-treatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a patient cohort with inoperable locally-advanced NSCLC treated with definitive chemoradiotherapy
15:25 - 15:25 | Author(s): O. Roengvoraphoj
- Abstract
Loading... -
+
74PD - Radiation-induced lung toxicity prediction modeling in NSCLC: Importance of baseline toxicity scoring
15:25 - 15:25 | Author(s): G. Defraene
- Abstract
Loading... -
+
Invited Discussant 73PD and 74PD
15:25 - 15:40 | Author(s): S. Senan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
15:40 - 15:45
- Abstract
No abstract available for this presentation
-
+
Immunotherapies and targeted therapies in advanced NSCLC
- Type: Proffered Paper session
- Presentations: 6
- Moderators:L. Paz-Ares
- Coordinates: 5/06/2017, 14:45 - 16:15, Room B
-
+
83O - A phase II study of durvalumab (MEDI4736) for previously treated patients with stage IV squamous NSCLC (SqNSCLC): Lung-MAP Sub-study SWOG S1400A
14:45 - 15:00 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
84O - Atezolizumab as first-line (1L) therapy for advanced non-small cell lung cancer (NSCLC) in PD-L1–selected patients: Efficacy data from the BIRCH trial
15:00 - 15:15 | Author(s): S. Peters
- Abstract
Loading... -
+
2O - Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture
15:15 - 15:30 | Author(s): G. Mazzaschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 83O, 84O and 2O
15:30 - 15:50 | Author(s): L. Paz-Ares
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
85O_PR - Patient-reported symptoms and impact of treatment with osimertinib vs chemotherapy for advanced non-small cell lung cancer
15:50 - 16:05 | Author(s): C.K. Lee
- Abstract
Loading... -
+
Invited Discussant 85O_PR
16:05 - 16:15 | Author(s): E. Smit
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Liquid biopsies in NSCLC
- Type: Educational session
- Presentations: 5
- Moderators:H. Wikman-Kocher
- Coordinates: 5/06/2017, 14:45 - 16:15, Room A
-
+
Blood-based techniques for detecting tumour-derived biomarkers in lung cancer
14:45 - 15:00 | Author(s): N. Normanno
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Detection of CTCs in peripheral blood of lung cancer
15:00 - 15:15 | Author(s): H. Wikman-Kocher
- Abstract
No abstract available for this presentation
-
+
Circulating blood platelets: A novel liquid biopsy biosource
15:15 - 15:30 | Author(s): T. Würdinger
- Abstract
No abstract available for this presentation
-
+
Role of cfDNA to monitor EGFR dynamic changes and resistance in blood
15:30 - 15:45 | Author(s): T.S.K. Mok
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Panel discussion
15:45 - 16:15
- Abstract
No abstract available for this presentation
-
+
Epidemiology and innovations in biomarker development
- Type: Poster Discussion session
- Presentations: 12
- Moderators:P. Boffetta
- Coordinates: 5/06/2017, 16:45 - 17:45, Room W
-
+
LBA3 - Correlation between clinical outcomes of patients treated within the tailor trial and next-generation sequencing (NGS) results: Analysis of genes associated to KRAS mutations
16:45 - 16:45 | Author(s): M. Ganzinelli
- Abstract
Loading... -
+
95PD - Diagnostic EGFR testing with ctDNA versus tumour in patients with advanced non-small cell lung cancer (NSCLC): The Royal Marsden experience
16:45 - 16:45 | Author(s): R. Kumar
- Abstract
Loading... -
+
Invited Discussant LBA3 and 95PD
16:45 - 17:00 | Author(s): S. Lantuejoul
- Abstract
No abstract available for this presentation
-
+
Discussion
17:00 - 17:05
- Abstract
No abstract available for this presentation
-
+
30PD_PR - Circulating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab
17:05 - 17:05 | Author(s): M. Tiseo
- Abstract
Loading... -
+
96PD_PR - Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR
17:05 - 17:05 | Author(s): A. Artal-Cortes
- Abstract
Loading... -
+
Invited Discussant 30PD_PR and 96PD_PR
17:05 - 17:20 | Author(s): R..A. Stahel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:20 - 17:25
- Abstract
No abstract available for this presentation
-
+
17PD - Patterns of lung cancer metastasis in the US population
17:25 - 17:25 | Author(s): M. Hendawi
- Abstract
Loading... -
+
18PD_PR - Optimal screening interval for detection of newly developed lung cancer: Comparison of sexual difference
17:25 - 17:25 | Author(s): M.Y. Kim
- Abstract
Loading... -
+
Invited Discussant 17PD and 18PD_PR
17:25 - 17:40 | Author(s): P. Boffetta
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:40 - 17:45
- Abstract
No abstract available for this presentation
-
+
New molecular targets of interest beyond ALK and EGFR
- Type: Educational session
- Presentations: 5
- Moderators:E. Smit
- Coordinates: 5/06/2017, 16:45 - 18:15, Room B
-
+
Targeting RAS
16:45 - 17:05 | Author(s): E. Smit
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Targeting B-RAF
17:05 - 17:25 | Author(s): D. Planchard
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Targeting NTRK
17:25 - 17:45 | Author(s): D. Signorelli
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Targeting MET
17:45 - 18:05 | Author(s): M. Awad
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Questions and Answers
18:05 - 18:15
- Abstract
No abstract available for this presentation
-
+
Targeted therapies and management of brain metastasis
- Type: Proffered Paper session
- Presentations: 7
- Moderators:D.P. Carbone
- Coordinates: 5/06/2017, 16:45 - 18:15, Room A
-
+
1O - ROS1 immunocytochemistry on cytological specimens in patients with non-small cell lung cancer
16:45 - 16:57 | Author(s): T. Vlajnic
- Abstract
Loading... -
+
86O - Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
16:57 - 17:09 | Author(s): E. Smit
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 1O and 86O
17:09 - 17:24 | Author(s): D.P. Carbone
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
3O - Innate resistance in EGFR mutant non-small cell lung cancer (NSCLC) patients by coactivation of receptor tyrosine kinases (RTKs)
17:24 - 17:36 | Author(s): R. Rosell
- Abstract
Loading... -
+
87O - Brigatinib in ALK+ NSCLC pts with intracranial CNS metastases in 2 clinical trials
17:36 - 17:48 | Author(s): M. Tiseo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
88O - CNS activity of ensartinib in ALK+ non-small cell lung cancer (NSCLC) patients (pts)
17:48 - 18:00 | Author(s): K.L. Reckamp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 3O, 87O and 88O
18:00 - 18:15 | Author(s): S. Popat
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Multiple lung nodules
- Type: Multidisciplinary Interactive Session (MIS)
- Presentations: 3
- Moderators:K. Suzuki
- Coordinates: 5/07/2017, 08:00 - 08:50, Room W
-
+
Staging: Diagnostic algorithms
08:00 - 08:15 | Author(s): F. Detterbeck
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Therapeutic algorithms
08:15 - 08:30 | Author(s): K. Suzuki
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
08:30 - 08:50
- Abstract
No abstract available for this presentation
-
+
Optimal management of stage III NSCLC in 2017
- Type: Multidisciplinary Interactive Session (MIS)
- Presentations: 3
- Moderators:S. Senan
- Coordinates: 5/07/2017, 08:00 - 08:50, Room A
-
+
Surgical approach
08:00 - 08:15 | Author(s): A.D.L.D.L. Sihoe
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Radiotherapy approach
08:15 - 08:30 | Author(s): S. Senan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
08:30 - 08:50
- Abstract
No abstract available for this presentation
first
prev
